ArticleJournal of translational medicine2020

Flow cytometry and targeted immune transcriptomics identify distinct profiles in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors with or without interferon-α.

Raquel Alves et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.